Linagliptin: The newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus

Rachael Aletti, Angela Cheng-Lai

Research output: Contribution to journalArticle

11 Scopus citations

Fingerprint Dive into the research topics of 'Linagliptin: The newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences